Effect of Non-invasive Magnetic Stimulation of the Brain on Breathlessness in Healthy Individuals. (AHrTMS)

April 23, 2026 updated by: Dr. Shakeeb H Moosavi, Oxford Brookes University

Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) of the Dorsolateral Prefrontal Cortex (DLPFC) on Hypercapnic Air Hunger Induced in Healthy Individuals.

The purpose of this study is to see if the front part of the brain called the "Dorsolateral Prefrontal Cortex" (DLPFC) has a role in our ability to feel breathlessness. The experiment will use a device that sits on the top of the head which produces a magnetic field that penetrates the scalp and excites the brain tissue directly under it. This procedure is called repetitive transcranial magnetic stimulation (rTMS), it is a painless procedure and known to be safe in healthy individuals. Previous research has shown that the pain felt when capsaicin, the active ingredient in 'chilli' powder, is applied to the hand is reduced by applying the rTMS on the scalp directly above the DLPFC part of the brain. In this experiment we want to see if breathlessness is also reduced. We will use a breathing task that will generate a moderate amount of breathlessness by adding a small amount of carbon dioxide to the inhaled air, while preventing the increase in the amount of breathing we would normally see in response to this. If we find that breathlessness produced by this breathing task is reduced after rTMS over the DLPFC, this may lead to new drugs that target this part of the brain in patients suffering from breathlessness due to heart or lung disease. The study will also improve our knowledge of how the brain enables us to feel breathlessness

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 0BP
        • Oxford Brookes University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

healthy individuals, over 18 years old, with no history of heart, lung or neurological conditions

Exclusion Criteria:

  • Any history of respiratory problems (including Asthma that involves regular use of inhalers)
  • Any history of heart or circulatory problems (e.g. palpitations, arrhythmias, angina, BP)
  • Any history of epilepsy, convulsions or seizures, migraines, or fainting
  • Any history of anxiety disorders (e.g. panic attacks)
  • Any history of serious head injury or brain surgery
  • Any metal parts in the head (except dental wire)
  • Any implants (e.g. pacemaker, insulin pump, neurostimulator)
  • Pregnancy or problems with alcohol or drug abuse.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stimulation of Left DLPFC
Intervention applied to Left DLPFC located by the BeamF3 technique
5 Hz rTMS applied using an actual coil over the left DLPFC
Active Comparator: Stimulation of Right DLPFC
Intervention applied to Right DLPFC located by the BeamF3 technique
5Hz rTMS applied using actual coil over Right DLPFC
Sham Comparator: Sham Stimulation
Sham intervention applied to either the left or right DLPFC
5Hz rTMS applied using sham coil over left or right DLPFC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Air hunger
Time Frame: Average of 4 steady state ratings in the last minute of air hunger tests
Ratings of air hunger on a 100mm Visual analog scale with the extremes defined as 'non' and 'tolerable limit'
Average of 4 steady state ratings in the last minute of air hunger tests

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bond Lader Mood questionnaire scores
Time Frame: Questionnaire administered immediately following pre and post intervention air hunger tests for how participants were feeling at that moment in time.
Ratings provided on a 100mm visual analogue scale anchored by a negative mood descriptor at one extreme and the opposing positive mood descriptor at the other extreme. The average scores for 'sedation' descriptors, 'discontentment' descriptors, and 'relaxation' descriptors are each expressed as %maximum
Questionnaire administered immediately following pre and post intervention air hunger tests for how participants were feeling at that moment in time.
Spielberger's state-trait anxiety inventory (STAI form Y-1 and form Y2) scores
Time Frame: Form Y-2 (trait anxiety) administered once on the initial practice day. Form Y-1 (state anxiety) administered immediately following pre and post intervention air hunger tests on test days.
20 is the lowest score and 80 is the highest score for both state (form Y-1) and trait (Form Y-2) anxiety
Form Y-2 (trait anxiety) administered once on the initial practice day. Form Y-1 (state anxiety) administered immediately following pre and post intervention air hunger tests on test days.
Dyspnoea-12 total, physical and emotion scores
Time Frame: Administered immediately following pre and post intervention air hunger tests in relation to the "test just completed"

For Total score; zero indicates no dyspnoea and 36 indicates worst possible dyspnoea (expressed as %fullscale).

For Physical score; zero indicates no dyspnoea in the physical domain and 21 indicates worst possible dyspnoea in physical domain (expressed as %fullscale).

For Emotion score; zero indicates no dyspnoea in emotion domian and 15 indicates worst possible dyspnoea in emotion domain (expressed as %fullscale).

Administered immediately following pre and post intervention air hunger tests in relation to the "test just completed"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Shakeeb H Moosavi, PhD, Oxford Brookes University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

May 16, 2024

Study Completion (Actual)

May 16, 2024

Study Registration Dates

First Submitted

November 12, 2022

First Submitted That Met QC Criteria

November 12, 2022

First Posted (Actual)

November 21, 2022

Study Record Updates

Last Update Posted (Actual)

April 29, 2026

Last Update Submitted That Met QC Criteria

April 23, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The de-identified IPD used in the results publication will be made available on the Oxford Brookes University Research and digital assets repository (RADAR)

IPD Sharing Time Frame

At the time of submission for journal publication of results

IPD Sharing Access Criteria

RADAR shares the intellectual product of Oxford Brookes University freely and openly, either with staff and students of Oxford brookes University or with the general public and global academic community

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyspnea

Clinical Trials on rTMS-L-DLPFC

Subscribe